---
title: "LeMaitre to Participate at Upcoming Investor Conferences in September | LMAT Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297232244.md"
description: "LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that its management, specifically CFO Dorian LeBlanc, will participate in three upcoming investor conferences in September 2026. These include the Wells Fargo Healthcare Conference on Sept. 8, the Morgan Stanley Global Healthcare Conference on Sept. 16, and the Barrington Research Virtual Fall Investment Conference on Sept. 22."
datetime: "2026-08-27T12:51:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297232244.md)
  - [en](https://longbridge.com/en/news/297232244.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297232244.md)
generator: "portal-rs"
---

# LeMaitre to Participate at Upcoming Investor Conferences in September | LMAT Stock News

See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google

Add on Google

BURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

**Wells Fargo 21****st** **Annual Healthcare Conference**  
Tuesday, September 8, 2026, in Boston  
Dorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET

**Morgan Stanley 24****th** **Annual Global Healthcare Conference**  
Wednesday, September 16, 2026, in New York City  
Dorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET

**19****th** **Annual Barrington Research Virtual Fall Investment Conference**  
Tuesday, September 22, 2026  
Dorian LeBlanc, CFO, time to be announced

**About LeMaitre**

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Contact:  
Sandra Millar  
LeMaitre Vascular, Inc.  
+1-781-425-1686  
ir@lemaitre.com

### Related Stocks

- [LMAT.US](https://longbridge.com/en/quote/LMAT.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [140,936 Shares of LeMaitre Vascular, Inc. $LMAT Purchased by Bank of America Corp DE](https://longbridge.com/en/news/300191757.md)
- [LMAT: Q2 2026 delivered double-digit sales and EPS growth, with strong margins and global expansion](https://longbridge.com/en/news/294865583.md)
- [Microsoft Could Be SpaceX's Next Big AI Customer: Bernstein Sees AI Revenue Surging Nearly 500%](https://longbridge.com/en/news/300953883.md)
- [Tesla's Q3 Delivery Beat Is Just the Start: Gene Munster Says TSLA Will ‘Crush Traditional Automakers’](https://longbridge.com/en/news/300968018.md)
- [Stifel lifts year-end target for S&P 500 to 7,900](https://longbridge.com/en/news/300948178.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**